Phase 3 Relapsing Remitting Multiple Sclerosis trials recruiting now

All Relapsing Remitting Multiple Sclerosis trials, every phase

Phase 3 Relapsing Remitting Multiple Sclerosis trials

• A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
  NCT05906992 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
  NCT04047628 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 23 locations
• RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
  NCT05758831 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 23 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.